Company news
Champions Oncology, Inc. news in 2025
Champions Oncology, Inc.'s news releases, calls and decks from 2025, newest first.
Champions Oncology Reports Record Quarterly Service Revenue of $14.9 Million
December 15, 2025
Champions Oncology to Announce Second Quarter Financial Results on Monday, December 15, 2025
December 8, 2025
CORRECTION: Champions Oncology Reports Quarterly Revenue of $14.0 Million
September 15, 2025
Champions Oncology Reports Record Quarterly Revenue of $14.0 Million
September 15, 2025
Champions Oncology to Announce First Quarter Financial Results on Monday, September 15, 2025
September 10, 2025
Champions Oncology Reports Record Annual Revenue of $57 Million
July 23, 2025
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Wednesday, July 23, 2025
July 21, 2025
Champions Oncology Announces Appointment of New CEO
July 18, 2025
Champions Oncology Launches Radiopharmaceutical Services Platform, Expands Isotope License, and Screens More Than 30 PDX Models
July 8, 2025
Champions Oncology Obtains Radioactive Materials License to Advance Comprehensive Radiotherapeutic Studies In-House
April 28, 2025
Champions Oncology's Data Platform Gains Momentum through a Strategic Collaboration with Turbine
April 24, 2025
Champions Oncology Reports Record Quarterly Revenue of $17.0 Million Record Net Income of $4.5 Million
March 11, 2025
Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 11, 2025
March 6, 2025
Champions Oncology Announces 17 Abstracts Accepted for Presentation at the 2025 American Association for Cancer Research Annual Meeting
February 18, 2025
Champions Oncology Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership
January 7, 2025
Calls in 2025
- Champions Oncology (NASDAQ:CSBR) Q2 2026 Earnings Call
Dec 15, 2025
Transcript - Champions Oncology (NASDAQ:CSBR) Q1 2026 Earnings Call
Sep 15, 2025
Transcript - Champions Oncology (NASDAQ:CSBR) Q4 2025 Earnings Call
Jul 23, 2025
Transcript - Champions Oncology (NASDAQ:CSBR) Q3 2025 Earnings Call
Mar 11, 2025
Transcript